Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Sep 29:S1534-5807(25)00539-8.
doi: 10.1016/j.devcel.2025.09.001. Online ahead of print.

Non-cell-autonomous tumor promotion in DICER1 cancer predisposition

Affiliations

Non-cell-autonomous tumor promotion in DICER1 cancer predisposition

Randolph K Larsen 4th et al. Dev Cell. .

Abstract

DICER1-related tumors are characterized by germline loss-of-function mutations in one DICER1 allele (DICER1+/-) and a somatic "second hit" mutation in the remaining DICER1 allele. Whether the germline DICER1+/- mutation participates in tumorigenesis is unknown. We show that germline heterozygous loss of Dicer1 promotes tumor formation via aberrant neutrophil function in spontaneous and allograft mouse models of rhabdomyosarcoma. Germline heterozygous deletion of Dicer1 decreased tumor latency and increased tumor penetrance, while conditional heterozygous deletion in tumor cells did not, illustrating that non-cell-autonomous contributions were required for tumor promotion. We show that Dicer1+/- murine and human tumors were enriched for neutrophils and that tumor-bearing mice had abundant circulating neutrophil extracellular traps (NETs). Genetically and pharmacologically preventing NET release reduced tumor promotion in Dicer1+/- mice, suggesting NETs promote tumor growth. These findings demonstrate that germline DICER1+/- mutations promote tumor growth and suggest that targeting neutrophils/NET release may reduce cancer risk in DICER1+/- individuals.

Keywords: DICER; DICER1; NETosis; PADI4; cancer predisposition; microRNA; neutrophil; pediatric cancer; rhabdomyosarcoma; sarcoma.

PubMed Disclaimer

Conflict of interest statement

Declaration of interests M.E.H. has served on the advisory board for Servier.

References

    1. Bernstein E, Caudy AA, Hammond SM, and Hannon GJ (2001). Role for a bidentate ribonuclease in the initiation step of RNA interference. Nature 409, 363–366. - PubMed
    1. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA, et al. (2005). MicroRNA expression profiles classify human cancers. Nature 435, 834–838. nature03702 [pii] 10.1038/nature03702. - DOI - PubMed
    1. Kumar MS, Pester RE, Chen CY, Lane K, Chin C, Lu J, Kirsch DG, Golub TR, and Jacks T (2009). Dicer1 functions as a haploinsufficient tumor suppressor. Genes Dev 23, 2700–2704. 10.1101/gad.1848209. - DOI - PMC - PubMed
    1. Hill DA, Ivanovich J, Priest JR, Gurnett CA, Dehner LP, Desruisseau D, Jarzembowski JA, Wikenheiser-Brokamp KA, Suarez BK, Whelan AJ, et al. (2009). DICER1 mutations in familial pleuropulmonary blastoma. Science 325, 965. 10.1126/science.1174334. - DOI - PMC - PubMed
    1. Schultz KAP, Stewart DR, Kamihara J, Bauer AJ, Merideth MA, Stratton P, Huryn LA, Harris AK, Doros L, Field A, et al. (1993). DICER1 Tumor Predisposition. In GeneReviews(®), Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, and Amemiya A, eds. (University of Washington, Seattle Copyright © 1993–2020, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.).

LinkOut - more resources